3Hainsworth JD, Fang L, Huang JE, et al. BRIDGE: an open-label phase II trim evaluating the safety of bevacizumab + carboplatin/paclitaxel as first-line treatment for patients with advanced, previously untreated, squamous non-small cell lung cancer[J]. J Thorac Oncol, 2011, 6 ( 1 ) :109-114.
4Ueno H, Naka H, Ohshita T,et al. Association between cerebral microbleeds on T2*-weighted MR images and recurrent hemorrhagic stroke in patients treated with warfarin following ischemic stroke [J]. AJNR Am J Neuroradiol ,2008, 29 ( 8 ):1483-1486.
5Cordonnier C, A1-Shahi Salman R, Wardlaw J. Spontaneousbrainmicrobleeds: systematic review, subgroup analyses and standards for study design and reporting[J]. Brain,2007, 130 ( Pt 8 ) :1988-2003.
6Fullerton HJ, Wu YW, Sidney S, et al. Recurrent hemorrhagic stroke in ehildren: a population-based cohort study[J]. Stroke,2007,38, ( 10 ) :2658- 2662.
7Bogucki J, Dabrowski P, Walasek N, et al. A new CT-based classification of spontaneous supratentorial intracerebral haematomas[J]. Neurol Neurochir Pol, 2009, 43 ( 3 ) :236-244.
8Wityk RJ. The management of blood pressure after stroke[J]. Neurologist, 2007, 13 (4):171-181.
9Aiyagari V, Gorelick PB: Management of blood pressure for acute and recurrent stroke[J]. Stroke, 2009, 40 ( 6 ) :2251-2256.
